MedPath

Comparison between high dose and low dose laser therapy (Nd:YAG laser) for facial pigmentation (melasma)

Not Applicable
Completed
Conditions
Health Condition 1: null- All patients of refractory melasma who have not shown complete clearance after 6 weeks of topical triple combination therapy and topical sunscreens attending the dermatology OPD
Registration Number
CTRI/2018/07/014864
Lead Sponsor
Department of Dermatology JIPMER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
36
Inclusion Criteria

All patients of refractory melasma who have not shown complete clearance after 6 weeks of topical triple combination therapy and topical sunscreens attending the dermatology OPD.

Exclusion Criteria

1. Other causes of facial melanosis (such as lichen planus pigmentosus, erythema dyschronicum perstans, pigmented contact dermatitis, post-inflammatory hyperpigmentation)

2. Pregnant and lactating mothers

3. Patients currently using oral contraceptives

4. History of endocrinopathies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath